← Leaderboards
Benjamin R Brooks
University Of Wisconsin Madison
$239,659
Attributed
$239,659
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$239,659 · 2
By mechanism
M01$239,659 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Paul M Sondel$16,210,986
- Stuart Johnston Knechtle$31,693,968
- Robert F Lemanske$29,535,752
- William W. Busse$100,295,147
- Michael M Altaweel$4,628,844
Others in their field
Top investigators on “Brain Disorder Chemotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Adam L Boxer · Mayo Clinic Rochester$30,350,302
- Keith A. Johnson · Banner Health$30,350,302
- Walter John Curran · Thomas Jefferson University$27,327,059
- Electra D. Paskett · Ohio State University$25,625,975
Research focus
Brain Disorder ChemotherapyClinical ResearchCorticosteroidsDrug Screening /EvaluationFunctional AbilityHormone TherapyHuman SubjectHuman Therapy EvaluationImmunotherapyLongitudinal Human StudyMagnetic Resonance ImagingMedical ComplicationMethylprednisoloneMonoclonal AntibodyMultiple SclerosisNeurologic ManifestationsOutcomes Research
Grant awards (5)
TAMOXIFEN THERAPY ON MEAN PERCENT PREDICTED ISOMETRIC STRENGTH IN ALS$749
M01 · FY2005 · RR
PHASE II STUDY OF HU23F2G IN ACUTE EXCERBATIONS OF MULTIPLE SCLEROSIS$106,600
M01 · FY2002 · RR
PHASE II STUDY OF HU23F2G IN ACUTE EXCERBATIONS OF MULTIPLE SCLEROSIS$106,600
M01 · FY2001 · RR
PHASE II STUDY OF HU23F2G IN ACUTE EXCERBATIONS OF MULTIPLE SCLEROSIS$12,855
M01 · FY2001 · RR
PHASE II STUDY OF HU23F2G IN ACUTE EXCERBATIONS OF MULTIPLE SCLEROSIS$12,855
M01 · FY2000 · RR